Original Source(s)
Related Content
Ensitrelvir Reduced COVID After Household Exposure
In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.
May 27, 2026
-
6 min
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
A Singular Approach to Combatting Infectious Disease
How single-cell analysis is evolving to improve vaccine development
May 18, 2026
-
5 min